公开(公告)号：US20230201293A1

公开(公告)日：2023-06-29

申请号：US17920888

申请日：2021-04-28

Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.

Inventor： He SUN ,  Xuefeng SU ,  Zhiyong ZHONG ,  Anni LI ,  Xijun YAN ,  Naifeng WU ,  Kaijing YAN

IPC: A61K36/537 ,  A61K36/258 ,  A61K31/05 ,  A61K9/51 ,  A61P11/00

CPC classification number: A61K36/537 ,  A61K36/258 ,  A61K31/05 ,  A61K9/5123 ,  A61K9/5161 ,  A61K9/5146 ,  A61P11/00

Abstract: The present invention relates to an application of a traditional Chinese medicine composition and formulation thereof in the preparation of medicaments for preventing and/or treating novel coronavirus pneumonia.